Conclusion:
We report a rare case of FSGS in a patient with SpA. Recognition of renal impairment in SpA is important in order to guide necessary nephroprotection measures and appropriate therapy before significant renal damage occurs. The diagnosis should be made by renal biopsy which in the majority of cases reveals amyloidosis or IgA nephropathy, however, in rare cases, some rare associations can be discovered.
Author Agreement 
I, Tbini Houssem, here by certify that all named authors have seen and approved the final version of the manuscript being submitted. I on behalf of all authors warrant that the article is the authors’ original work, hasn’t received prior publication and isn’t under consideration for publication elsewhere. I confirm that the order of authors listed in the manuscript has been approved by all of them.
Authors understand that the Corresponding Author is the sole contact for the Editorial process. He is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs.
Conflict of Interest Declaration:
Authors declare having no conflict of interest.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.